Product Information
MEMANTINE-DONEPEZIL ER 14-10 MG is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $6.4882 per EA under NDC 69238124803. Its NADAC has been published 63 times since Jul 23, 2025.
FDA first approved this application on Jan 27, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 14 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238124803
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208328FDA Approved
1/27/2017
TE Code
AB
On Market Since
2/1/2017
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE-DONEPEZIL ER 14-10 MG has been published 63 times since Jul 23, 2025, and over the history we have for it it has declined 60.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.4882 per EA |
|---|---|
| All-time high | $16.5827 (Aug 13, 2025) |
| All-time low | $6.4882 (Sep 23, 2026) |
| 52-week high | $15.9298 |
| 52-week low | $6.4882 |
| Median price | $12.8530 |
| Average price | $12.5054 |
| Largest weekly change | -13.1% (Aug 19, 2026) |
| Weeks tracked | 63 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Memantine and Donepezil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Memantine and Donepezil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEMANTINE-DONEPEZIL ER 14-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE-DONEPEZIL ER 14-10 MG, manufactured by Amneal Pharmaceuticals NY LLC, is $6.4882 per EA (NDC 69238124803), effective Sep 30, 2026.
How has the price of MEMANTINE-DONEPEZIL ER 14-10 MG changed over time?
Over the history we have for it, the NADAC for MEMANTINE-DONEPEZIL ER 14-10 MG has declined 60.9%. It has been tracked across 63 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for MEMANTINE-DONEPEZIL ER 14-10 MG?
Since Jul 23, 2025, the NADAC for MEMANTINE-DONEPEZIL ER 14-10 MG has ranged from a low of $6.4882 (Sep 23, 2026) to a high of $16.5827 (Aug 13, 2025), with a median of $12.8530 per EA.
Are there cheaper alternatives to MEMANTINE-DONEPEZIL ER 14-10 MG?
No other NADAC-published product currently shares the active ingredient and strength of MEMANTINE-DONEPEZIL ER 14-10 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MEMANTINE-DONEPEZIL ER 14-10 MG?
MEMANTINE-DONEPEZIL ER 14-10 MG (NDC 69238124803) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.